Effects of reproductive factors on risk of breast cancer: A literature review

Asian Pacific Journal of Cancer Prevention

Volumn 10, Issue 4, 2009, Pages 545-550

  Parsa, Parisa ^a   Parsa, Bita ^b  

^a HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY PUTRA MALAYSIA   (Malaysia)

Author keywords

Breast cancer reproductive factors risk factors hormones

Indexed keywords

EID: 77951104749     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Brind J, Chinchilli V, Severs W, Summy-Long J (1996). Induced abortion as an independent risk factor for breast cancer: a comprehensive review and meta-analysis. J Epidemiol Community Health, 50, 481-96.
2. Cerhan R, Kushi LH, Olson JE, et al (2000). Twinship and risk of postmenopausal breast cancer. J Natl Cancer Inst, 92, 261-5.
3. Chen C, Weiss N, Newcomb P, et al (2002). Hormone replacement therapy in relation to breast cancer. J Am Med Assoc, 287, 734-41.
4. Chie W, Hsieh C, Newcomb P, et al (2000). Age at any full-term pregnancy and breast cancer risk. Am J Epidemiol, 151, 715-22.
5. Collaborative Group on Hormonal Factors in Breast Cancer (1996). Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies. Lancet, 347, 1713-27.
6. Collaborative Group on Hormonal Factors in Breast Cancer (2002). Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease. Lancet, 360, 187-95.
7. Collaborative Group on Hormonal Factors in Breast Cancer (2004). Breast cancer and abortion: collaborative reanalysis of data from 53 epidemiological studies, including 83 000 women with breast cancer from 16 countries. Lancet, 363, 1007-16.
8. Clavel-Chapelon F, E3n-EPIC Group (2002). Differential effects of reproductive factors on the risk of pre-and postmenopausal breast cancer. results from a large cohort of French women. Br J Cancer, 86, 723-7.
9. De Stavola B, dos Santos Silva I, Mccormack V, et al (2004). Childhood growth and breast cancer. Am J Epidemiol, 159, 671-82.
10. Enger S, Ross R, Henderson B (1997). Breast feeding history, pregnancy experience and risk of breast cancer. Br J Cancer, 76, 118-23.
11. Goldman MB; Hatch MC (2000). Breast cancer epidemology, treatment, and prevention. In: Ursin G, Spicer D (Eds) Women and Health. London: Academic Press, 871-83.
12. Grubbs CJ, Farnell DR, Hill DL, McDonough KC (1985). Chemoprevention of N-nitroso-N-methylurea-induced mammary cancers by pretreatment with 17 beta-estradiol and progesterone. J Natl Cancer Inst, 74, 927-31.
13. Harrison R, Smith D, Greene P, Kratt P (1999). Relationship between relative risk of developing breast cancer and absolute risk in population of rural, older African American women. Breast J, 5, 364-68.
14. Innes KE, Byers TE (1999). Preeclampsia and breast cancer risk. Epidemiology, 10, 722-32.
15. International Agency for Research on Cancer IARC (1999). Monographs on the evaluation of carcinogenic risk of chemicals to humans. Some hormones, postmenopausal hormone therapy, and hormonal contraception. Lyon: IARC, 721,660.
16. John E, Horn-Ross PL, Koo J (2003). Lifetime physical activity and breast cancer risk in a multiethnic population: the San Francisco Bay area breast cancer study. Cancer Epidemiol Biomarkers Prev, 12, 1143-52.
17. Lee C, Ko I S, Kim HS, Lee WH, et al (2004). Development and validation study of the breast cancer risk appraisal for Korean women. Nurs Health Sci, 6, 201-7.
18. Macmahon B (1993). General motors cancer research prizewinners laureates lectures. In: Charles S, Mott P (Eds) Reproduction and cancer of the breast. Cancer, 71, 3185-8.
19. Marchbanks P, Mcdonald J, Wilson H, et al (2002). Oral contraceptives and the risk of breast cancer. N Engl J Med, 346, 2025-32.
20. Magnusson CM, Persson IR, Baron JA, et al (1999). The role of reproductive factors and use of oral contraceptives in the aetiology of breast cancer in women aged 50 to 74 years. Int J Cancer, 80, 231-6.
21. Mctiernan A, Kooperberg C, White E, et al (2003). Women's Health Initiative Cohort Study. Recreational physical activity and the risk of breast cancer in postmenopausal women. JAMA, 290, 1331-6.
22. Michels KB, Trichopoulos D, Robins JM, et al (1996). Birth weight as a risk factor for breast cancer. Lancet, 348, 1542-6.
23. Nagata C, Hu Yh, Shimizu H (1995). Effects of menstrual and reproductive factors on the risk of breast cancer: metaanalysis of the case-control studies in Japan. Jpn J Cancer Res, 86, 910-5.
24. National Institutes of Health 2004 [on line]. Asks participants in women's health initiative estrogen-alone study to stop study pills, begin follow-up phase. http://www.nhlbi.nih.gov/new/press/04-03-02.htm.
25. Newcomb P, Titus-Ernstoff L, Egan K, et al (2002). Postmenopausal estrogen and progestin use in relation to break cancer risk. Cancer Epidemiol Biomarkers Prev, 11, 593-600.
26. Oran B, Celik I, Erman M, Baltali E, et al (2004). Analysis of menstrual, reproductive, and life-style factors for breast cancer risk in Turkish women: a case-control study. Med Oncol, 21, 31-40.
27. Parker L (2001). Breast feeding and cancer prevention. Eur J Cancer, 37, 155-8.
28. Ponten J, Holmberg L, Trichopoulos D, et al (1990). Biology and natural history of breast cancer. Int J Cancer, 5 (suppl), 5-21.
29. Ross RK, Paganini-Hill A, Wan PC, Pike MC (2000). Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin. J Natl Cancer Inst, 92, 328-32.
30. Russo IH, Russo J (1998). Role of hormones in mammary cancer initiation and progression. J Mammary Gland Biol Neoplasia, 3, 49-61.
31. Russo IH, Russo J (2000). Hormonal approaches to breast cancer prevention. J Cell Biochem, 34 (supp 1), 1-6.
32. Russo J, Russo IH (1999). Cellular basis of breast cancer susceptibility. Oncol Res, 1, 169-78.
33. Russo J, Gusterson BA, Rogers AE, Russo IH, et al (1990). Comparative study of human and rat mammary tumorigenesis. Lab Invest, 62, 244-78.
34. Schairer C, Lubin J, Troisi R, et al (2000). Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. J Am Med Assoc, 283, 485-91.
35. Sivaraman L, Stephens LC, Markaverich BM, et al (1998). Hormone-induced refractoriness to mammary carcinogenesis in Wistar-Furth rats. Carcinogenesis, 19, 1573-81.
36. Tamakoshi K, Yatsuya H, Wakai K, Suzuki S, et al (2005). Impact of menstrual and reproductive factors on breast cancer risk in Japan: Results of the JACC study. Cancer Sci, 96, 57-62.
37. Tamakoshi K, Wakai K, Kojima M, Watanabe Y, et al (2004). A prospective study on the possible association between having children and colon cancer risk: Findings from the JACC study. Cancer, 95, 243-7.
38. Tryggvadottir L, Tulinius H, Eyfjord JE, Sigurvinsson T (2002). Breast cancer risk factors and age at diagnosis: an Icelandic cohort study. Int J Cancer, 98, 604-8.
39. Van Den Brandt P, Spiegelman D, Yaun S, et al (2000). Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol, 152, 514-27.
40. Weiss N, Stanford J, Daling J (2000). Hormone replacement therapy in relation to risk of lobular and ductal breast carcinoma in middle-aged women. Cancer, 88, 2570-77.
41. Wingo P, Newsome K (1997). The risk of breast cancer following spontaneous and induced abortion. Cancer Causes Control, 8, 93-108.
42. Wrensch M, Chew T, Farren G, et al (2003). Risk factors for breast cancer in population with high incidence rates. Breast Cancer Res, 5, 88-102.
43. Zografos GC, Panou M, Panou N (2004). Common risk factors of breast and ovarian cancer: recent review. Int J Gynecol Cancer, 14, 721-40.